Home/Filings/4/0001209191-20-048698
4//SEC Filing

CLARKE JOHN K 4

Accession 0001209191-20-048698

CIK 0001339970other

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 9:09 PM ET

Size

8.6 KB

Accession

0001209191-20-048698

Insider Transaction Report

Form 4
Period: 2020-08-26
CLARKE JOHN K
DirectorOther
Transactions
  • Sale

    Common Stock

    2020-08-27$4.09/sh5,440$22,250117,943 total(indirect: See Footnote)
  • Sale

    Common Stock

    2020-08-26$4.30/sh2,200$9,451123,383 total(indirect: See Footnote)
Holdings
  • Common Stock

    7,492
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.245 to $4.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F2]There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.245, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Issuer

aTYR PHARMA INC

CIK 0001339970

Entity typeother

Related Parties

1
  • filerCIK 0001219015

Filing Metadata

Form type
4
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 9:09 PM ET
Size
8.6 KB